A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Clinical trial NCT04925206 · TERMINATED

Trial details

NCT number: NCT04925206
Sponsor: EdiGene (GuangZhou) Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Transfusion Dependent Beta-Thalassaemia

Start date: 2021-08-17
Primary completion: 2024-01-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.